DEPVEN XL Extended release tablet Ref.[50494] Active ingredients:

Source: Health Products Regulatory Authority (ZA)  Revision Year: 2020  Publisher: CIPLA MEDPRO (PTY) LTD, Building 9, Parc du Cap, Mispel Street, Belville, 7530, RSA Company Contact Details: Phone: +27 21 943 4200 Customer Care: 080 222 6662, E-mail: info@cipla.com

Product name and form

DEPVEN 50 XL, 50 mg extended release tablets.

DEPVEN 100 XL, 100 mg extended release tablets.

Pharmaceutical Form

Film coated, extended release tablets.

DEPVEN 50 XL, 50 mg extended release tablets are light pink coloured, round, biconvex, film coated tablets, debossed with ‘50’ on one side and plain on other side.

DEPVEN 100 XL, 100 mg extended release tablets are dark brown to red coloured, round, biconvex, film coated tablets, debossed with ‘100’ on one side and plain on other side.

Qualitative and quantitative composition

DEPVEN 50 XL: Each extended release tablet contains desvenlafaxine succinate equivalent to desvenlafaxine 50 mg.

DEPVEN 100 XL: Each extended release tablet contains desvenlafaxine succinate equivalent to desvenlafaxine 100 mg.

For the full list of excipients, see Section 6.1.

List of Excipients

Hypromellose (Benecel K100M PHARM CR)
Hypromellose (Methocel K100LV CR)
Magnesium stearate
Microcrystalline cellulose (Comprecel M 101)
Povidone K-90
Purified water
Talc
Opadry Pink 03F84770 (for 50 mg formulation)
Opadry Brown 03F86990 (for 100 mg formulation)

Contents of the film-coating:

Opadry Pink 03F84770:

HPMC 2910/Hypromellose (6cP)
Iron oxide red.
Macrogol/PEG 6000
Talc
Titanium dioxide

Opadry Brown 03F86990:

HPMC 2910/Hypromellose (6cP)
Iron oxide black
Iron oxide red.
Macrogol/PEG 4000
Titanium dioxide

Pack sizes and marketing

DEPVEN XL Extended Release Tablets are packed in Blister and HPDE bottle pack(s). Such blisters and/or HDPE bottles are further packed in a Carton along with Pack Insert.

Marketing authorization holder

CIPLA MEDPRO (PTY) LTD, Building 9, Parc du Cap, Mispel Street, Belville, 7530, RSA

Company Contact Details: Phone: +27 21 943 4200
Customer Care: 080 222 6662, E-mail: info@cipla.com

Drugs

Drug Countries
DEPVEN South Africa
 
Next: Usage >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈